Clinical trials: Secondary Pancreatic Diabetes, open to volunteers
Pancreatic Cancer
Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes
The purpose of this study is to evaluate the efficacy of anti-diabetic treatment on improving the overall survival for metastatic pancreatic cancer patients complicated by diabetes receiving gemcitabine and nab-paclitaxel…
- Trial name
- PTCA199-16 (NCT07272109)
- Testing
- Nab-paclitaxel, Gemcitabine (1000 mg/m2), Anti-Diabetics
- Where
- China
- Volunteers
- 210 people
- Sponsor
- Fudan University